---
figid: PMC3228973__jnm-17-338-g004
figlink: /pmc/articles/PMC3228973/figure/F4/
number: Figure 4
caption: Proposed signal transduction pathways in nodose ganglia following receptor
  activation with leptin and cholecystokinin-8 (CCK-8). There are 2 potential pathways
  for phosphorylation of signal transducer and activator of transcription 3 (STAT3).
  Leptin activates Janus kinase-2 phosphorylation at tyrosine 1138, which directly
  phosphorylates STAT3, or leptin activates phophoinositide 3-kinase (PI3K) via the
  insulin receptor substrate, leading to STAT3 phosphorylation. CCK-8 activates PI3K
  via SRC and RhoA, which leads to phosphorylation of STAT3, suggesting that PI3K
  is central to the synergistic leptin/CCK STAT3 phosphorylation. The mitogen-activated
  protein kinase (MAPK) inhibitor PD98059 had no effect on leptin and CCK-8 synergism,
  suggesting that the leptin/CCK-8-stimulated MAPK/ extracellular signal-regulated
  kinase 1/2 pathway was not involved in STAT3 phosphorylation. STAT3 usually acts
  by stimulating the transcription of target genes, but the rapid electrophysiological
  effects suggest STAT3 may be involved in modifying the activity of K+ channels.
  CCKAR, CCK-A receptor; LRb, leptin receptor b; PKC, protein kinase C; JAK2, Janus
  kinase-2; IRS, insulin receptor substrate; SHP2, SH2 domain-containing tyrosine
  phosphatase 2; ERK, extracellular signal-regulated kinase; MEK, MAPK/ERK kinase;
  ATF-1, activating transcription factor-1; CRE, cAMP response element-binding protein;
  AP-1, activator protein-1. Adapted from Heldsinger et al.
pmcid: PMC3228973
papertitle: Vagal Control of Satiety and Hormonal Regulation of Appetite.
reftext: Chung Owyang, et al. J Neurogastroenterol Motil. 2011 Oct;17(4):338-348.
pmc_ranked_result_index: '178521'
pathway_score: 0.9570565
filename: jnm-17-338-g004.jpg
figtitle: Proposed signal transduction pathways in nodose ganglia following receptor
  activation with leptin and cholecystokinin-8 (CCK-8)
year: '2011'
organisms: Homo sapiens
ndex: 53f95443-dee4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3228973__jnm-17-338-g004.html
  '@type': Dataset
  description: Proposed signal transduction pathways in nodose ganglia following receptor
    activation with leptin and cholecystokinin-8 (CCK-8). There are 2 potential pathways
    for phosphorylation of signal transducer and activator of transcription 3 (STAT3).
    Leptin activates Janus kinase-2 phosphorylation at tyrosine 1138, which directly
    phosphorylates STAT3, or leptin activates phophoinositide 3-kinase (PI3K) via
    the insulin receptor substrate, leading to STAT3 phosphorylation. CCK-8 activates
    PI3K via SRC and RhoA, which leads to phosphorylation of STAT3, suggesting that
    PI3K is central to the synergistic leptin/CCK STAT3 phosphorylation. The mitogen-activated
    protein kinase (MAPK) inhibitor PD98059 had no effect on leptin and CCK-8 synergism,
    suggesting that the leptin/CCK-8-stimulated MAPK/ extracellular signal-regulated
    kinase 1/2 pathway was not involved in STAT3 phosphorylation. STAT3 usually acts
    by stimulating the transcription of target genes, but the rapid electrophysiological
    effects suggest STAT3 may be involved in modifying the activity of K+ channels.
    CCKAR, CCK-A receptor; LRb, leptin receptor b; PKC, protein kinase C; JAK2, Janus
    kinase-2; IRS, insulin receptor substrate; SHP2, SH2 domain-containing tyrosine
    phosphatase 2; ERK, extracellular signal-regulated kinase; MEK, MAPK/ERK kinase;
    ATF-1, activating transcription factor-1; CRE, cAMP response element-binding protein;
    AP-1, activator protein-1. Adapted from Heldsinger et al.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - STAT5A
  - STAT2
  - STAT4
  - EIF2AK3
  - STAT1
  - MAP2K1
  - SRC
  - PRKD3
  - PTPN11
  - PRKCD
  - STAT5B
  - STAT6
  - MAP2K2
  - PRKCZ
  - PRKCG
  - PRKCQ
  - NRAS
  - IRS4
  - JAK2
  - CCKAR
  - PRKCH
  - PRKCI
  - PRKCA
  - HRAS
  - RHOA
  - IRS1
  - FOS
  - IRS2
  - PRKCE
  - PRKCB
  - LUC7L3
  - KRAS
  - Cancer
genes:
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: (p-ERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Ras-
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: CCKAR
  symbol: CCKAR
  source: hgnc_symbol
  hgnc_symbol: CCKAR
  entrez: '886'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Ras-
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: C-FOS
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: CRE-AP-1
  symbol: CREAP-1
  source: hgnc_alias_symbol
  hgnc_symbol: LUC7L3
  entrez: '51747'
- word: Ras-
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
